)
Rex Harrison Cano has over 25 years of experience, primarily in business journalism, tracking and analysing the Indian stock market. An avid market enthusiast and a proficient technical analyst, Rex believes that charts and numbers come to life to tell stories of past and possible future journeys.
Rex Harrison Cano has over 25 years of experience, primarily in business journalism, tracking and analysing the Indian stock market. An avid market enthusiast and a proficient technical analyst, Rex believes that charts and numbers come to life to tell stories of past and possible future journeys.
Meanwhile, brokerage firm Nomura has retained its 'Buy' rating on Larsen & Toubro post Q4 results; but lowered the target price.
Weekly market outlook, May 12 - 16, 2025: Key momentum oscillators on the daily and weekly technical charts indicate a mixed outlook for the BSE Sensex and the NSE Nifty in the near-term.
For the Nifty 50 index to hit the lower circuit, it has to fall 10 per cent to 21.846.20 levels on Friday. If this becomes a reality before 1 PM, then the trading will be halted for 45 minutes
Technical charts indicate that shares of these 3 tyre-manufacturers can potentially rally up to another 19% from present levels; check details here
Trent, Raymond, ACC, SBI, Tata Steel and Reliance were among the consistent gainers in one-month period post India-Pakistan conflicts, shows analysis of 262 commonly traded stocks during these periods
Here's a technical outlook on 5 stocks across the auto, textiles and alcoholic beverages sector. Check stocks & strategy.
Shares of Glenmark, Chambal Fertilisers, Blue Dart, Max Healthcare and CCL Products may trade with a positive bias in the near-term as these stocks are favourably placed on the technical charts.
The Nifty has near-support at 24,200, below which the key support will be the 200-DMA at 24,050 levels, shows the technical chart.
BEL, BDL, Mazagon Dock, HAL, Solar Inds, Astra Micro and Data Patterns seem favourably placed on the charts, and may gain up to 38%; here are key support, resistance levels for these 7 defence stocks.
FIIs net bought over 30,000 contracts of Nifty futures in the last five days; thereby taking their long-short ratio to 0.94 - its highest point since October 4, 2024; shows the NSE derivatives data.
Technical chart indicates that the bias at the YES Bank counter is likely to remain tepid as long as the stock trades below this particular resistance zone; here are the key levels to watch out for.
Shares of Adani Group can rally up to 20% from present levels, as key stocks - Adani Ports, Adani Green and Adani Total Gas crossed their key moving averages after a long-gap, technical charts show.
Technical charts indicate a likely mixed outlook for state-run banking shares. Bank of Baroda and IOB stocks seem to be favourably placed, while PNB and Canara Bank may witness downward pressure.
Technically, the stock has near support at ₹ 960; below which the most important support level coincides with the key indicator on the weekly and monthly charts. Check key levels here
Weekly market outlook, May 5 - 9, 2025: Sensex and Nifty seem favourably placed on charts; however, key momentum oscillators are showing signs of tiring out, hence an interim dip cannot be ruled out.
Indus Towers, Godrej Agrovet, Phoenix Mills, Ajanta Pharma and Star Health stocks dropped up to 12% in intra-day deals on Friday; here are the key levels to track on these 5 stocks.
The NSE Nifty has been struggling below its weekly trend line resistance since October 25, 2024; a breakout can potentially trigger a 6 per cent rally on the index, suggests technical charts.
Kalyan Jewellers stock has swung over 40% twice so far in 2025, and over 30% four times in the last four months. Technical chart suggests that the stock could potentially rally over 25% from here on.
Technically, the short-term trend for IndusInd Bank looks favourable; but chart cautions that stock may face challenges around its 100-DMA, and the weekly trend line resistance. Check key levels here
Analysts believe that pharma shares continue to see buying interest, given the inelastic demand for medicines; tariffs, if any could have minimal impact on the industry.